These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 34919819)

  • 1. The BRCT domain of PARP1 binds intact DNA and mediates intrastrand transfer.
    Rudolph J; Muthurajan UM; Palacio M; Mahadevan J; Roberts G; Erbse AH; Dyer PN; Luger K
    Mol Cell; 2021 Dec; 81(24):4994-5006.e5. PubMed ID: 34919819
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
    Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Poly(ADP-ribose) polymerase 1 searches DNA via a 'monkey bar' mechanism.
    Rudolph J; Mahadevan J; Dyer P; Luger K
    Elife; 2018 Aug; 7():. PubMed ID: 30088474
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of Nucleosome Reorganization by PARP1.
    Maluchenko NV; Nilov DK; Pushkarev SV; Kotova EY; Gerasimova NS; Kirpichnikov MP; Langelier MF; Pascal JM; Akhtar MS; Feofanov AV; Studitsky VM
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.
    Matkarimov BT; Zharkov DO; Saparbaev MK
    Mutagenesis; 2020 Feb; 35(1):107-118. PubMed ID: 31782485
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A PARP1-BRG1-SIRT1 axis promotes HR repair by reducing nucleosome density at DNA damage sites.
    Chen Y; Zhang H; Xu Z; Tang H; Geng A; Cai B; Su T; Shi J; Jiang C; Tian X; Seluanov A; Huang J; Wan X; Jiang Y; Gorbunova V; Mao Z
    Nucleic Acids Res; 2019 Sep; 47(16):8563-8580. PubMed ID: 31291457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPF1 and nucleosomes mediate a dramatic switch in activity of PARP1 from polymerase to hydrolase.
    Rudolph J; Roberts G; Muthurajan UM; Luger K
    Elife; 2021 Mar; 10():. PubMed ID: 33683197
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure and dynamics of the chromatin remodeler ALC1 bound to a PARylated nucleosome.
    Bacic L; Gaullier G; Sabantsev A; Lehmann LC; Brackmann K; Dimakou D; Halic M; Hewitt G; Boulton SJ; Deindl S
    Elife; 2021 Sep; 10():. PubMed ID: 34486521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
    Alemasova EE; Lavrik OI
    Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The WD40 domain of FBXW7 is a poly(ADP-ribose)-binding domain that mediates the early DNA damage response.
    Zhang Q; Mady ASA; Ma Y; Ryan C; Lawrence TS; Nikolovska-Coleska Z; Sun Y; Morgan MA
    Nucleic Acids Res; 2019 May; 47(8):4039-4053. PubMed ID: 30722038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PARP Power: A Structural Perspective on PARP1, PARP2, and PARP3 in DNA Damage Repair and Nucleosome Remodelling.
    van Beek L; McClay É; Patel S; Schimpl M; Spagnolo L; Maia de Oliveira T
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34066057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PARP1 exhibits enhanced association and catalytic efficiency with γH2A.X-nucleosome.
    Sharma D; De Falco L; Padavattan S; Rao C; Geifman-Shochat S; Liu CF; Davey CA
    Nat Commun; 2019 Dec; 10(1):5751. PubMed ID: 31848352
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple roles for PARP1 in ALC1-dependent nucleosome remodeling.
    Ooi SK; Sato S; Tomomori-Sato C; Zhang Y; Wen Z; Banks CAS; Washburn MP; Unruh JR; Florens L; Conaway RC; Conaway JW
    Proc Natl Acad Sci U S A; 2021 Sep; 118(36):. PubMed ID: 34465625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanistic Insights into Autoinhibition of the Oncogenic Chromatin Remodeler ALC1.
    Lehmann LC; Hewitt G; Aibara S; Leitner A; Marklund E; Maslen SL; Maturi V; Chen Y; van der Spoel D; Skehel JM; Moustakas A; Boulton SJ; Deindl S
    Mol Cell; 2017 Dec; 68(5):847-859.e7. PubMed ID: 29220652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.
    Frigon L; Pascal JM
    Nucleic Acids Res; 2023 Dec; 51(22):12492-12507. PubMed ID: 37971310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PAR recognition by PARP1 regulates DNA-dependent activities and independently stimulates catalytic activity of PARP1.
    Deeksha W; Abhishek S; Rajakumara E
    FEBS J; 2023 Nov; 290(21):5098-5113. PubMed ID: 37462479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.
    Suskiewicz MJ; Zobel F; Ogden TEH; Fontana P; Ariza A; Yang JC; Zhu K; Bracken L; Hawthorne WJ; Ahel D; Neuhaus D; Ahel I
    Nature; 2020 Mar; 579(7800):598-602. PubMed ID: 32028527
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Single-Molecule Atomic Force Microscopy Study of PARP1 and PARP2 Recognition of Base Excision Repair DNA Intermediates.
    Sukhanova MV; Hamon L; Kutuzov MM; Joshi V; Abrakhi S; Dobra I; Curmi PA; Pastre D; Lavrik OI
    J Mol Biol; 2019 Jul; 431(15):2655-2673. PubMed ID: 31129062
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.
    Shao Z; Lee BJ; Rouleau-Turcotte É; Langelier MF; Lin X; Estes VM; Pascal JM; Zha S
    Nucleic Acids Res; 2020 Sep; 48(17):9694-9709. PubMed ID: 32890402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MORC2 regulates DNA damage response through a PARP1-dependent pathway.
    Zhang L; Li DQ
    Nucleic Acids Res; 2019 Sep; 47(16):8502-8520. PubMed ID: 31616951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.